[HTML][HTML] Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes

S Pesce, S Trabanelli, C Di Vito, M Greppi, V Obino… - Cancers, 2020 - mdpi.com
… successful cancer immunotherapy strategies … innate lymphocytes by ICI in both solid tumors
and hematological malignancies. Overall, we believe that, in our near future, immunotherapy

Targeting innate immune pathways for cancer immunotherapy

LL Cao, JC Kagan - Immunity, 2023 - cell.com
… The innate immune system is critical for inducing durable and protective T cell responses to
… for cancer immunotherapy. In this review, we present a framework wherein distinct innate

[HTML][HTML] Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on γδ T and NK cells

F Morandi, M Yazdanifar, C Cocco, A Bertaina, I Airoldi - Cells, 2020 - mdpi.com
… The use of iNKT TCR in cancer immunotherapy has shown … a bi-potential innate lymphocyte
can be exploited for treating … NK cells are bone marrow-derived innate lymphocytes capable …

Innate lymphoid cells and cancer

N Jacquelot, C Seillet, E Vivier, GT Belz - Nature Immunology, 2022 - nature.com
… Despite the unprecedented success of this first wave of cancer immunotherapies based
on immune checkpoint inhibitors and CAR T cells, many people fail to benefit from such …

Chimeric antigen receptor-and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy

C Zhang, Y Hu, W Xiao, Z Tian - Cellular & Molecular Immunology, 2021 - nature.com
… CAR- and NKR-engineered innate killer cells for use in cancer immunotherapy Innate
lymphocytes constitute a heterogeneous group of cells that includes innate lymphoid cells (ILCs, …

Harnessing innate immunity using biomaterials for cancer immunotherapy

DY Lee, K Huntoon, Y Wang, W Jiang… - Advanced …, 2021 - Wiley Online Library
… of innate immune system to enhance cancer immunotherapy. We highlight the design principles
of various biomaterials used for innate … -based cancer immunotherapy for clinical trials/…

[HTML][HTML] Targeting innate immunity in cancer therapy

S Rameshbabu, BW Labadie, A Argulian, A Patnaik - Vaccines, 2021 - mdpi.com
… The majority of current cancer immunotherapy strategies target and potentiate antitumor
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited to …

Targeting the innate immune system with nanoparticles for cancer immunotherapy

K Li, Z Zhang, Y Mei, M Li, Q Yang, Q Wu… - Journal of Materials …, 2022 - pubs.rsc.org
cancer immunotherapy, the recent studies presented in this review prove that
nanoparticle-incorporated cancer immunotherapy is a highly promising treatment for cancer patients. …

[HTML][HTML] Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer

Y Chen, Z Tian - Cellular & molecular immunology, 2021 - nature.com
innate lymphocytes with tissue residency has gradually become the focus of research. In this
review, we address the current knowledge regarding hepatic innate lymphocytescancer. A …

[HTML][HTML] Innate immune cells and their contribution to T-cell-based immunotherapy

P Ginefra, G Lorusso, N Vannini - International journal of molecular …, 2020 - mdpi.com
innate immune cells in the context of cancer immunotherapy. In this review, we describe the
contribution of innate immune cells in T-cell-based cancer immunotherapycancer patients. …